Kensington Investment Counsel’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$248K Sell
2,107
-3,134
-60% -$438K 0.12% 82
2025
Q4
$859K Sell
5,241
-2,851
-35% -$447K 0.35% 72
2025
Q3
$1.08M Sell
8,092
-1,025
-11% -$125K 0.44% 66
2025
Q2
$1.13M Sell
9,117
-210
-2% -$26.7K 0.49% 60
2025
Q1
$1.19M Sell
9,327
-368
-4% -$56.6K 0.53% 56
2024
Q4
$1.4M Sell
9,695
-346
-3% -$49.6K 0.58% 55
2024
Q3
$1.49M Buy
10,041
+184
+2% +$26.4K 0.62% 50
2024
Q2
$1.24M Buy
9,857
+34
+0.3% +$5.33K 0.55% 56
2024
Q1
$1.81M Buy
9,823
+2,115
+27% +$403K 0.83% 46
2023
Q4
$1.39M Sell
7,708
-22
-0.3% -$3.42K 0.73% 52
2023
Q3
$1.23M Buy
7,730
+312
+4% +$51K 0.76% 48
2023
Q2
$1.05M Sell
7,418
-122
-2% -$19.6K 0.67% 56
2023
Q1
$1.27M Sell
7,540
-1,773
-19% -$316K 0.96% 44
2022
Q4
$1.58M Hold
9,313
1.24% 35
2022
Q3
$1.74M Buy
9,313
+39
+0.4% +$8.22K 1.47% 26
2022
Q2
$1.51M Buy
9,274
+4,402
+90% +$696K 1.28% 31
2022
Q1
$916K Sell
4,872
-3,741
-43% -$711K 0.61% 70
2021
Q4
$2.28M Buy
+8,613
New +$2.32M 1.33% 26
2021
Q2
$1.52M Buy
7,628
+177
+2% +$34.3K 1.05% 44
2021
Q1
$1.45M Buy
7,451
+463
+7% +$94.9K 1.09% 44
2020
Q4
$1.34M Buy
+6,988
New +$1.27M 1.11% 38

Other funds holding RGEN

Kensington Investment Counsel's RGEN Position: Q1 2026 in Review

Kensington Investment Counsel reduced its Repligen (RGEN) stake by 60% in Q1 2026, selling an estimated $438K and leaving 2,107 shares worth $248K. The position accounts for 0.12% of the portfolio, ranked #82.

Kensington Investment Counsel first reported a position in RGEN in Q4 2020 and has held it in 21 quarters since. The position peaked at $2.28M in Q4 2021. 442 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Kensington Investment Counsel held 2,107 shares of Repligen worth $248K as of Q1 2026.
  • Kensington Investment Counsel sold 3,134 Repligen shares in Q1 2026, an estimated $438K.
  • Repligen made up 0.12% of Kensington Investment Counsel's portfolio in Q1 2026, its #82 holding.
  • Kensington Investment Counsel first reported a position in Repligen in Q4 2020 and has held it in 21 quarters since.
  • Kensington Investment Counsel's Repligen position peaked at $2.28M in Q4 2021.
  • 442 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Kensington Investment Counsel's 13F filing for Q1 2026, filed 19 May 2026.